Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 562.32M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -22.73M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -8.00% |
| Sales | 11.2M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -3.00% |
| Dividend | N/A | Price/Book | 10.97 | EPS next 5Y | - | 52W High Chg | -32.00% |
| Recommedations | - | Quick Ratio | 14.57 | Shares Outstanding | 237.24M | 52W Low Chg | 43.00% |
| Insider Own | 25.62% | ROA | -2.14% | Shares Float | 183.24M | Beta | 0.95 |
| Inst Own | 15.26% | ROE | -16.20% | Shares Shorted/Prior | -/- | Price | 2.38 |
| Gross Margin | -15.30% | Profit Margin | -203.02% | Avg. Volume | 1,474 | Target Price | - |
| Oper. Margin | -33.46% | Earnings Date | Aug 28 | Volume | 1,508 | Change | -7.03% |
About SILEX SYSTEMS
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.